ERBB2 and orbit neoplasm: Both chemotherapy and combination therapy (hormonal therapy plus chemotherapy) for this invasive ductal cancer with endocrine differentiation (hormone receptor-positive, HER2-negative) was significantly effective against both the breast and orbital tumors.